In case of CKD, the use of a GLP-1RA with proven cardiovascular benefit is only recommended in those who have not achieved individualized glycemic targets despite SGLT2i treatment, or in whom SGLT2is are contraindicated or not tolerated [6, 8]
Available from: Bawa T, Dhingra V, Malhotra N, Wasir JS, Mithal A
Each system is evaluated with explicit attention to the evidence supporting biological relevance, the reasons for historical underexploration, and the translational questions that must be addressed to enable renewed development
lucidum , Pleurotus ostreatus , and Cordyceps militaris , have demonstrated the ability to modulate glycemic response ( -cells and Langerhans islets
Patient-reported outcomes are superior in patients with type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study